Iluvien 0.19 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQWM6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,707
Award facts
- Contract value 100% obligated
- $13,707.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,707.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for ILUVIEN 0.19 mg implants, with an ultimate completion date of February 19, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499,999,999 ceiling value and extends through December 31, 2036.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains a comprehensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations globally. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical supply needs to military healthcare facilities worldwide, with DMS Pharmaceutical Group serving as one of multiple regional prime vendor contractors. No subcontractors are associated with this award.
Quick answers
Who was awarded contract SPE2DR26FQWM6?
SPE2DR26FQWM6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQWM6 worth?
The government has obligated $13,707 on SPE2DR26FQWM6.
Is contract SPE2DR26FQWM6 an order under another contract?
Yes. SPE2DR26FQWM6 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWM6 competed?
The extent of competition for SPE2DR26FQWM6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award